Endo
Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack
March 27, 2018Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma
Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …
Endo granted injunction to block blood pressure competitor
March 2, 2018Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin
Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block competitor …
Endo pulls plug on Alabama plant, 875 jobs lost
July 25, 2017Manufacturing and Production Endo, Qualitest, biotech, drugs, generics, pharma, pharmaceutical
Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of …
Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug
August 15, 2016Sales and Marketing Endo, Endo International, abuse deterrent, opioid
Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
Endo lands a big fish with $8 billion Par Pharma deal
May 19, 2015Sales and Marketing Endo, Valeant, par pharma
Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …
Pharma M&A trail continues as Pfizer buys slice of Dutch biotech
May 12, 2015Sales and Marketing Endo, Pfizer, aspen, merger
Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …
Valeant sprints ahead of Endo to secure Salix
March 18, 2015Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix
Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …
Endo attempts to outbid Valeant for Salix Pharma
March 12, 2015Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix
Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …
Endo buys Auxilium for $2.6 billion
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum
Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …
Perception of pharma online ‘negative’
October 25, 2012Medical Communications, Sales and Marketing Digital Health Coalition, Endo, WEGO Health
Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …
Endo says Opana ER supply disruption will be temporary
February 28, 2012Manufacturing and Production Endo, Novartis, Opana ER
Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …
